Genomic reporting for laboratories
From a genotype file to a report your lab can stand behind.
Atlagene analyses genotyping files across 21 categories, shows what each file actually covers, and prepares a report in your laboratory’s name for your team’s clinical review.
How a report run works
Five steps, and the limits stay visible at every one.
Upload the export
Start with the file your assay already produces. Its format is checked before anything is analysed.
See the coverage
Each category shows how much of its panel the file actually covers. Gaps stay visible instead of reading as normal.
Analyse 21 categories
One reviewed variant registry drives every category, built on ClinVar, the GWAS Catalog and PharmGKB.
Review clinically
Safety-critical findings are marked variant by variant and stay in full detail whatever the report settings. Your team decides who reviews them before reports reach patients.
Deliver in your name
A PDF report in your laboratory’s branding, ready for your team’s review and sign-off.
The report
A report in your laboratory’s name, with its limits on the page.
Every category shows how much of its panel the file measured. Where the data are too thin to rank a result, the report says so beside it.
Report R-0001
Results summary
Coverage is the share of each category’s panel that this file measured.
- Pharmacogenomics94% coverageElevated2 variants carried
- Cardiovascular88% coverageAverageNo variants carried
- Rare disease31% coverageAverageCoverage-limitedNot ranked against the population
- Oncology76% coverageAverage1 variant carried
Built around how a laboratory runs.
The portal is for your staff, your volume and your obligations to patients.
Accounts for your team
Lab staff sign in with a one-time code sent to their phone and can add an authenticator app as a second factor. There are no shared passwords to manage.
Pay per test
No subscription. Volume tiers lower the price per test as your monthly volume grows.
Genomic data kept apart
Genotype data and identity data live in separate databases, reached through separate connections.
Access on the record
Access to patient data is written to an audit log.
How we treat evidence
A result is only as good as what the file measured.
Coverage, not confidence.
Genotyping arrays test a fraction of known variants. Every result states how much of its panel the file covered.
Silence is not reassurance.
A position the file never measured is left out of the result. It is never read as a normal finding.
Reviewed before it is live.
Variant definitions are drafted, then countersigned by a reviewer before any report can use them.
Bring us your assay.
Tell us what you run, who reads the report and what you want an evaluation to answer. We reply with a scoped plan.